Identification of HER2-over-expression, HER2-low-expression, and HER2-zero-expression statuses in breast cancer based on 18F-FDG PET/CT radiomics
Abstract Purpose According to the updated classification system, human epidermal growth factor receptor 2 (HER2) expression statuses are divided into the following three groups: HER2-over-expression, HER2-low-expression, and HER2-zero-expression. HER2-negative expression was reclassified into HER2-l...
Saved in:
| Main Authors: | Xuefeng Hou, Kun Chen, Huiwen Luo, Wengui Xu, Xiaofeng Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Cancer Imaging |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40644-025-00880-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
[18F]FDG PET/CT volumetric biomarkers for non-invasive prediction of HER2 expression in breast cancer patients
by: Mai ELahmadawy, et al.
Published: (2025-01-01) -
Predictive significance of 18F-FDG PET/CT metabolic parameters for the expression level of HER2 in gastric cancer
by: Zhang Shilai, et al.
Published: (2025-04-01) -
A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)Key Points:
by: Maeve A. Hennessy, et al.
Published: (2025-06-01) -
Intratumoral and peritumoral ultrasound radiomics analysis for predicting HER2-low expression in HER2-negative breast cancer patients: a retrospective analysis of dual-central study
by: Jiajia Wang, et al.
Published: (2025-06-01) -
Preoperative prediction of HER2 expression and sentinel lymph node status in breast cancer using a mammography radiomics model
by: Ziqian Zhao, et al.
Published: (2025-06-01)